Junior Group Leader in “Cancer Systems Biology”
Kennziffer: 2025-0010
- München
- Full-time
- DKFZ/DKTK Division of Translational Oncology, LMU
„Forschen für ein Leben ohne Krebs“ – das ist unsere Aufgabe am Deutschen Krebsforschungszentrum. Wir erforschen, wie Krebs entsteht, erfassen Krebsrisikofaktoren und suchen nach neuen Strategien, die verhindern, dass Menschen an Krebs erkranken. Wir entwickeln neue Methoden, mit denen Tumore präziser diagnostiziert und Krebspatient:innen erfolgreicher behandelt werden können. Jeder Beitrag zählt – ob in der Forschung, in der Administration oder der Infrastruktur. Das macht unsere tägliche Arbeit so bedeutungsvoll und spannend.
Together with selected university partner sites, the DKFZ has established the German Cancer Consortium (DKTK). The alliance between the DKFZ as the core center and the university partner sites in Berlin, Dresden, Essen/Düsseldorf, Frankfurt/Mainz, Freiburg, Heidelberg, Munich and Tübingen establishes joint translation centers at the University Medical Centers of each of the partner sites.
The DKTK contributes significantly to filling the translational gap between basic and clinical cancer research, thereby developing new strategies for personalized oncology in prevention, diagnosis and treatment of cancer. DKTK conducts transformative translational cancer research, educates the next generation of translation-oriented medical and clinical scientists and establishes strong pipelines towards clinical cancer research and the economy. Further information can be found at www.dktk.org.
The German Cancer Research Center (DKFZ) is seeking for the partner site Munich of the German Cancer Consortium (DKTK) from May 2025 a
Under the leadership of Prof. Martin Sos, head of the Division of Translational Oncology at the DKTK partner site Munich, we are seeking to appoint a junior group leader to expand our efforts in the field of functional and computational cancer biology. The scientific interest should match with the profile of the DKTK partner site Munich and the Ludwig-Maximilians-University Munich (LMU Munich) with a focus on lung cancer and the evolution of drug resistance to support and further develop the translational cancer research portfolio.
The DKTK partner site Munich and the DKFZ provide access to first-class, state-of-the-art core facilities in Munich and Heidelberg. Translational research activities are supported by access to large patient cohorts, high quality tumor tissue banks and excellent clinical research facilities. The junior group leader will be employed at the DKFZ in Heidelberg, whereas the junior group will be physically located in Munich, embedded in the Division of Translational Oncology (headed by Prof. Martin Sos; DKTK/LMU; Max-Lebsche-Platz, Munich).
Ihre Aufgaben:
We are open to applicants coming from other fields of solid tumor research, with the precondition to align their strategy complementary to the Division of Translational Oncology. Competitive applicants are expected to establish innovative analytical pipelines for high-dimensional transcriptomic, epigenomic and proteomic data and to test their findings in functional models including genetically defined mouse models. The group will be situated in a preclinical translational area with an emphasis on reverse translation and the development of novel treatments. The group is expected to cooperate with clinician scientists and help to shape the design of future clinical trials.
Ihr Profil:
- M.Sc. (biology, molecular biology, computational biology or similar)
- Ph.D. and/or M.D. degree in medicine or life sciences
- Excellent postdoctoral experience (max. up to 6 years) in a research area that matches the DKTK partner site Munich profile (https://dktk.dkfz.de/en/sites/munich)
- Deep understanding of functional and computational cancer biology
- Record of accomplishments (publications and third-party funding) that highlights the applicant`s vision for future functional and computational cancer biology projects
- Expectation to acquire competitive national and international third-party funding
- Vision for an internationally competitive innovative research program
- Strong motivation to interact/collaborate cross-disciplinary and across sites with research groups within the DKFZ and DKTK
- Ability to work independently and as part of a team
- Excellent command of written and oral English
Applications of medical scientists as well as clinician scientists are welcome. Applications should include a CV, list of publications and a 2-page research synopsis that summarizes current/past research accomplishments and outlines the candidate´s research program for the next 6 years. Applications should include contact details of at least two referees.
The position is limited to 6 years. An extension beyond the 6-year period is not possible. The position does not include a tenure option.
Unser Angebot:
- Hervorragende Rahmenbedingungen: modernste state-of-the-art Infrastruktur und Möglichkeit zum internationalen Austausch auf Spitzenniveau
- Basic endowment of the junior group for up to six years
- 30 Tage Urlaub
- Flexible Arbeitszeiten
- Vergütung nach TV-L inkl. betrieblicher Altersvorsorge und vermögenswirksamer Leistungen
- Möglichkeit zur mobilen Arbeit und Teilzeitarbeit
- Familienfreundliches Arbeitsumfeld
- Nachhaltig zur Arbeit: Vergünstigtes Deutschland-Jobticket
- Entfalten Sie Ihr volles Potenzial: gezielte Angebote für Ihre persönliche Entwicklung fördern Ihre Talente
- Unser betriebliches Gesundheitsmanagement bietet ein ganzheitliches Angebot für Ihr Wohlbefinden
Sie sind interessiert?
Prof. Dr. Martin Sos
Telefon: 0221-478 96175
